Viewing Study NCT03608358


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-03 @ 10:20 PM
Study NCT ID: NCT03608358
Status: TERMINATED
Last Update Posted: 2022-05-31
First Post: 2018-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module